Do you want to improve your writing? Try our new evaluation service and get detailed feedback.
Check Your Text it's free

Throughout Friday, relatives of the eminent journalist Hassan Shahriar and doctors treating him were looking to get their hands on an Actemra injection. The drug was one of their last hopes to save his life. He was battling Covid-19 in the intensive care unit (ICU) of a private hospital in the capital. The drug was not found. Shahriar breathed his last on Saturday. Many more critical Covid-19 patients like Shahriar who doctors say could have had a better chance of surviving with an Actemra injection have died recently amid a massive shortage of the drug in the country. However, the importer of the injection in the country, Radiant Pharmaceuticals Ltd, said the next consignment of the injection will arrive within the next two or three days and will reduce the crisis. Dr Nirupam Das, chief administrator of the Bangladesh Doctors Foundation, who also tried to get the drug for Shahriar, told The Business Standard, "I have searched at all the Radiant booths from Friday afternoon but

Throughout Friday, relatives of the eminent journalist Hassan Shahriar and doctors treating him were looking to get their hands on an Actemra injection. The drug was one of their last hopes to save his life. He was battling Covid-19 in the intensive care unit (ICU) of a private hospital in the capital. The drug was not found. Shahriar breathed his last on Saturday. Many more critical Covid-19 patients like Shahriar who doctors say could have had a better chance of surviving with an Actemra injection have died recently amid a massive shortage of the drug in the country. However, the importer of the injection in the country, Radiant Pharmaceuticals Ltd, said the next consignment of the injection will arrive within the next two or three days and will reduce the crisis. Dr Nirupam Das, chief administrator of the Bangladesh Doctors Foundation, who also tried to get the drug for Shahriar, told The Business Standard, "I have searched at all the Radiant booths from Friday afternoon but D2966
Throughout Friday, relatives of the eminent journalist Hassan Shahriar and doctors treating him were looking to get their hands on an Actemra injection. The drug was one of their last hopes to save his life. He was battling Covid-19 in the intensive care unit (ICU) of a private hospital in the capital. The drug was not found. Shahriar breathed his last on Saturday. Many more critical Covid-19 patients like Shahriar who doctors say could have had a better chance of surviving with an Actemra injection have died recently amid a massive shortage of the drug in the country. However, the importer of the injection in the country, Radiant Pharmaceuticals Ltd, said the next consignment of the injection will arrive within the next two or three days and will reduce the crisis. Dr Nirupam Das, chief administrator of the Bangladesh Doctors Foundation, who also tried to get the drug for Shahriar, told The Business Standard, "I have searched at all the Radiant booths from Friday afternoon but the injection was not found anywhere. This injection produces good results among patients in the ICU. There is a huge demand for it, but Radiant is importing it in very low numbers. " Actemra is a drug used mainly for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. Health workers have been using it to treat critical Covid-19 patients. Demand for the drug has recently sky-rocketed across the country amid the second wave of the Covid-19 pandemic, creating a massive shortage in its supply. According to health officials, the Actemra injection is producing positive results among critical patients in the ICU. Dr Shoman Aniruddha, an anesthesiologist at the ICU of Mugda General Hospital, told the Business Standard, "Although there has been no specific publication (research) about it, we have seen that the injection creates a positive response in 10-20% of critical Covid-19 patients, especially among those who require a high level of oxygen. But now the supply of the injection in demand ratio has turned very low. " Dr Shoman said the drug is not supplied by any hospital. Relatives of patients are asked to purchase it and provide it to health officials to be used for patients' treatment. The injection was first used in a limited range in treating critical Covid-19 patients during the first wave of the infection in the country. At the time, a patient's relatives would be able to get the medicine just by contacting Radiant's booth. But now, one has to submit a prescription, patient's name, hospital's name to Radiant in order to get the medicine, Dr Shoman added.
Throughout Friday, relatives of the eminent journalist Hassan
Shahriar
and doctors treating him were looking to
get
their hands on an Actemra
injection
. The
drug
was one of their last hopes to save his life. He was battling Covid-19 in the intensive care unit (ICU) of a private hospital in the capital. The
drug
was not found.
Shahriar
breathed his last on Saturday.

Many
more
critical
Covid-19
patients
like
Shahriar
who doctors say could have had a better chance of surviving with an Actemra
injection
have
died
recently amid a massive shortage of the
drug
in the country.

However
, the importer of the
injection
in the country,
Radiant
Pharmaceuticals Ltd, said the
next
consignment of the
injection
will arrive within the
next
two or three days and will
reduce
the crisis.

Dr
Nirupam
Das
, chief administrator of the Bangladesh Doctors Foundation, who
also
tried to
get
the
drug
for
Shahriar
,
told
The Business Standard,
"
I have searched at all the
Radiant
booths from Friday afternoon
but
the
injection
was not found anywhere. This
injection
produces
good
results among
patients
in the ICU. There is a huge demand for it,
but
Radiant
is importing it in
very
low numbers.
"


Actemra is a
drug
used
mainly
for the treatment of rheumatoid arthritis and systemic juvenile idiopathic arthritis. Health workers have been using it to treat
critical
Covid-19
patients
. Demand for the
drug
has recently sky-rocketed across the country amid the second wave of the Covid-19 pandemic, creating a massive shortage in its supply.

According to health officials, the Actemra
injection
is producing
positive
results among
critical
patients
in the ICU.

Dr
Shoman
Aniruddha
, an anesthesiologist at the ICU of
Mugda
General Hospital,
told
the Business Standard,
"
Although there has been no specific publication (research) about it, we have
seen
that the
injection
creates a
positive
response in 10-20% of
critical
Covid-19
patients
,
especially
among those who require a high level of oxygen.
But
now
the supply of the
injection
in demand ratio has turned
very
low.
"


Dr
Shoman
said the
drug
is not supplied by any hospital. Relatives of
patients
are asked
to
purchase
it and provide it to health officials to be
used
for patients' treatment.

The
injection
was
first
used
in a limited range in treating
critical
Covid-19
patients
during the
first
wave of the infection in the country. At the time, a patient's relatives would be able to
get
the medicine
just
by contacting Radiant's booth.
But
now
, one
has to
submit a prescription, patient's name, hospital's name to
Radiant
in order to
get
the medicine, Dr
Shoman
added
.
What do you think?
  • This is funny writingFunny
  • I love this writingLove
  • This writing has blown my mindWow
  • It made me angryAngry
  • It made me sadSad

IELTS essay Throughout Friday, relatives of the eminent journalist Hassan Shahriar and doctors treating him were looking to get their hands on an Actemra injection. The drug was one of their last hopes to save his life. He was battling Covid-19 in the intensive care unit (ICU) of a private hospital in the capital. The drug was not found. Shahriar breathed his last on Saturday. Many more critical Covid-19 patients like Shahriar who doctors say could have had a better chance of surviving with an Actemra injection have died recently amid a massive shortage of the drug in the country. However, the importer of the injection in the country, Radiant Pharmaceuticals Ltd, said the next consignment of the injection will arrive within the next two or three days and will reduce the crisis. Dr Nirupam Das, chief administrator of the Bangladesh Doctors Foundation, who also tried to get the drug for Shahriar, told The Business Standard, "I have searched at all the Radiant booths from Friday afternoon but

Essay
  American English
9 paragraphs
432 words
5.5
Overall Band Score
Coherence and Cohesion: 5.5
  • Structure your answers in logical paragraphs
  • ?
    One main idea per paragraph
  • Include an introduction and conclusion
  • Support main points with an explanation and then an example
  • Use cohesive linking words accurately and appropriately
  • Vary your linking phrases using synonyms
Lexical Resource: 5.0
  • Try to vary your vocabulary using accurate synonyms
  • Use less common question specific words that accurately convey meaning
  • Check your work for spelling and word formation mistakes
Grammatical Range: 6.5
  • Use a variety of complex and simple sentences
  • Check your writing for errors
Task Achievement: 5.0
  • Answer all parts of the question
  • ?
    Present relevant ideas
  • Fully explain these ideas
  • Support ideas with relevant, specific examples
Labels Descriptions
  • ?
    Currently is not available
  • Meet the criteria
  • Doesn't meet the criteria
Recent posts





Get more results for topic: